Zobrazeno 1 - 10 of 492 pro vyhledávání: '"L Holmvang"'
1
Low-dose dobutamine infusion and single-dose tocilizumab in acute myocardial infarction patients with high risk of cardiogenic shock development - rationale and design of the DOBERMANN trial
Autor: J Bo Kunkel, M Frydland, S Duus Holle, J Kjaergaard, R Pecini, L Evi Bang, P Palm, S Wiberg, L Holmvang, T Engstroem, J Loenborg, J Eifer Moeller, J Hartvig Thomsen, C Hassager, H Soeholm
Publikováno v: European Heart Journal: Acute Cardiovascular Care. 12
Funding Acknowledgements Type of funding sources: Foundation. Main funding source(s): Novo Nordisk Fonden Background Cardiogenic shock (CS) is seen in up to 10% of patients with ST-elevation myocardial infarction (STEMI) and is associated with a high
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::650f6cefca5f4c0da514cff194de041d
https://doi.org/10.1093/ehjacc/zuad036.131
Zobrazit plný text záznamu
2
Long-term survival and return to work after refractory out-of-hospital cardiac arrest managed with extracorporeal cardiopul-monary resuscitation; a nationwide follow-up study
Autor: E Gregers, K Kragholm, S R Moerk, L Linde, J A Boending, C J Terkelsen, J F Lassen, J E Moeller, H Laugesen, M Smerup, J Kjaergaard, P H Moeller-Soerensen, L Holmvang, C Hassager, H Soeholm
Publikováno v: European Heart Journal: Acute Cardiovascular Care. 12
Funding Acknowledgements Type of funding sources: Foundation. Main funding source(s): Rigshospitalets and Odense Universitetshospitals common foundation Background Survival after refractory out-of-hospital cardiac arrest (OHCA) is low. Extracorporeal
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::88239d82c112c5532e612456a3b38c9c
https://doi.org/10.1093/ehjacc/zuad036.136
Zobrazit plný text záznamu
3
Atrial fibrillation is associated with mortality and increased admission biomarkers reflecting neurohormonal activation and inflammation in patients with ST-elevation myocardial infarction
Autor: M Frydland, J E Moeller, L Holmvang, O K L Helgestad, L O Jensen, J P Goetze, C Hassager
Publikováno v: European Heart Journal: Acute Cardiovascular Care. 12
Funding Acknowledgements Type of funding sources: Foundation. Main funding source(s): Righospitalets Forskningsfond (07IO) Lundbeck Foundation (R186-2015-2132). Background Neurohormonal activation and inflammation is associated with mortality in STEM
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3d7e0199939bd10c145c10c1f0ef70b7
https://doi.org/10.1093/ehjacc/zuad036.083
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
High bleeding risk in all-comers with ST-segment elevation myocardial infarction and use of P2Y12-inhibitiors
Autor: M R Jacobsen, R Jabbari, T Engstroem, E L Grove, C Glinge, F Pedersen, L Holmvang, L Koeber, C Torp-Pedersen, M Maeng, K Veien, P Freeman, M G Charlot, H Kelbaek, R Soerensen
Publikováno v: European Heart Journal. 43
Background Bleeding has an important prognostic impact in patients with ST-segment elevation myocardial infarction (STEMI), yet stratification of bleeding risk to guide dual antiplatelet therapy (DAPT) is not routinely performed in clinical practice.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9e69430a38906db23bd9b8e2237d9240
https://doi.org/10.1093/eurheartj/ehac544.1270
Zobrazit plný text záznamu
7
The value of coronary computed tomography and very early invasive coronary angiography compared to standard intervention in older patients after non-ST segment elevation acute coronary syndromes
Autor: H Ratcovich, G Sadjadieh, J J Linde, F R Joshi, H Kelbaek, K F Kofoed, L V Koeber, P Riis Hansen, C Torp-Pedersen, H Elming, G Gislason, D E Hoefsten, T Engstoem, L Holmvang
Publikováno v: European Heart Journal. 43
Background The optimal management of patients with non-ST elevation acute coronary syndromes (NSTEACS) remains a challenge. The merits of both computed tomography angiography (CTA) as a rule-out test for significant coronary artery disease and early
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::530abb2d7023993ecb516f775ba2ac37
https://doi.org/10.1093/eurheartj/ehac544.1441
Zobrazit plný text záznamu
8
Comparative diagnostic and prognostic implications of right versus left bundle branch block in patients with suspected ST-segment elevation myocardial infarction
Autor: N A Soerensen, Y Fakhri, A Gossling, J T Neumann, P M Haller, B Toprak, J Lehmacher, R Twerenbold, D Westermann, H Andersson, L O Jensen, L Holmvang, S Blankenberg, P Clemmensen
Publikováno v: European Heart Journal. 43
Background Current ESC guidelines on management of acute myocardial infarction in patients presenting with ST-segment elevation (STEMI) recommend emergent invasive management in patients with ischemic symptoms and bundle branch block (BBB). While lef
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c9f83116e3733f9879f8989c2e06800f
https://doi.org/10.1093/eurheartj/ehac544.1426
Zobrazit plný text záznamu
9
Soluble suppression of tumorigenicity associated to post-procedural no-or-slow-reflow phenomenon in ST-elevation myocardial infarction
Autor: F Sondergaard, R Beske, M Frydland, O Helgestad, L O Jensen, L Holmvang, T Engstroem, J E Moeller, C Hassager
Publikováno v: European Heart Journal. 43
Background Over the last decades, the prognosis for patients with ST-elevation myocardial infarction (STEMI) has improved due to primary percutaneous coronary intervention (pPCI). However, no-or-slow-reflow phenomenon after pPCI constrains this benef
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::09d2c6d38ef81a2b1f185c5112861eb8
https://doi.org/10.1093/eurheartj/ehac544.1357
Zobrazit plný text záznamu
10
Misclassification rate of the angiographically identified culprit lesion in NSTEMI
Autor: K Ekstroem, J Loenborg, L Nepper-Cristensen, L Holmvang, F R Joshi, A Z Iversen, P L Madsen, N T Olsen, F Pedersen, R Soerensen, H H Tilsted, N G Vejlstrup, M R J Jensen, T Engstroem
Publikováno v: European Heart Journal. 43
Background Correct identification of the culprit lesion in NSTEMI is essential, in particular for patients in whom a culprit-only strategy is attractive (e.g., elderly and frail patients). However, when identifying the culprit lesion in NSTEMI, angio
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::96fecc0a8f60854d5a0ed081ded4416f
https://doi.org/10.1093/eurheartj/ehac544.1202
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje